Molecular Genetics
|
Scheme Provider |
Scheme |
|
UKNEQAS for Blood Coagulation |
Thrombophilia Genotyping – Factor V Leiden Mutation and Prothrombin Mutation 20210A |
|
UKNEQAS for Molecular Genetics |
Molecular testing on bloodspots – Cystic Fibrosis (CF) |
|
UKNEQAS for Molecular Genetics |
Molecular testing on bloodspots – Medium Chain acyl-CoA dehydrogenase deficiency (MCADD) |
|
UKNEQAS for Molecular Genetics |
Familial Hypercholesterolaemia (FH) |
|
UKNEQAS for Molecular Genetics |
Fragile X |
|
UKNEQAS for Molecular Genetics |
Microsatellite Instability (MSI) |
|
UKNEQAS for Molecular Genetics |
Pathogenicity of sequence variants pilot scheme |
|
UKNEQAS for Molecular Genetics |
Charcot-Marie-Tooth neuropathy type 1A & hereditary neuropathy with liability to pressure palsies |
|
UKNEQAS for Molecular Genetics |
Myotonic Dystrophy Type 1 Interpretation |
|
UKNEQAS for Molecular Genetics |
Medium Chain acyl-CoA dehydrogenase deficiency (MCADD) full scheme |
|
UKNEQAS for Molecular Genetics |
Cystic Fibrosis (CF) full scheme |
|
UKNEQAS for Molecular Genetics |
Huntington Disease |
|
UKNEQAS for Molecular Genetics |
Spinal muscular atrophy |
|
EMQN |
AZF testing (Y chromosome microdeletion analysis) |
|
EMQN |
BRCA testing (BRCA1 and BRCA2 analysis) |
|
EMQN |
DFNB1 testing (Sensorineural deafness) |
|
EMQN |
PKU (PAH gene analysis) |
|
EMQN |
FH (familial hypercholesterolaemia) |
|
EMQN |
HFE (haemochromatosis) |
|
EMQN |
Sanger DNA sequencing |
Cytogenetics
|
Scheme Provider |
Scheme |
|
CEQAS |
Chorionic villus Sampling (CVS) |
|
CEQAS |
Blood/FISH |
|
CEQAS |
Amniotic Fluid |
|
CEQAS |
Products of conception/fetal tissue analysis |
|
Sample swap |
Solid tissue for telomere analysis |
Molecular Cytogenetics
|
Scheme Provider |
Scheme |
|
UKNEQAS for Molecular Genetics |
Maternal Cell Contamination and Sexing |
|
CEQAS |
Microarray |
|
CEQAS |
Molecular Rapid Aneuploidy (MRA) |
Oncology Genetics
|
Scheme Provider |
Scheme |
|
EuroMRD |
Ig/TCR based minimal residual disease analysis |
|
EuroMRD |
MLL based minimal residual disease analysis |
|
CEQAS |
Lymphoproliferative disease (LPD) |
|
CEQAS |
Myeloid Leukaemia (AML, MDS, CML) |
|
CEQAS |
Tumour |
|
CEQAS |
B or T Lymphoblastic leukaemia |
|
UKNEQAS for Leucocyte Immunophenotyping |
Hairy Cell Leukaemia BRAF mutation V600E pilot scheme |
|
UKNEQAS for Leucocyte Immunophenotyping |
BCR/ABL Quantitation |
|
UKNEQAS for Leucocyte Immunophenotyping |
IGH/TCR Clonality |
|
CEQAS |
Adult Molecular Neuropathology pilot scheme |
|
UKNEQAS for Molecular Pathology |
Melanoma (BRAF gene) |
|
UKNEQAS for Molecular Pathology |
Non-small cell lung cancer (EGFR gene and ALK gene rearrangement) |
|
UKNEQAS for Molecular Pathology |
Colorectal cancer (KRAS) |
|
UKNEQAS for Leucocyte Immunophenotyping |
Paediatric Acute Leukaemia Translocation (PALT) pilot scheme |
|
UKNEQAS for Leucocyte Immunophenotyping |
FMS-Like Tyrosine-3 (FLT3 gene) status |
|
UKNEQAS for Leucocyte Immunophenotyping |
JAK2 V617F status |
|
UKNEQAS for Leucocyte Immunophenotyping |
Nucleophosmin testing (NPM1) |
|
UKNEQAS for Molecular Genetics |
Breast Cancer (BRCA1 and BRCA2 genes) full scheme |
|
UKNEQAS for Leucocyte Immunophenotyping |
BCR-ABL Kinase domain mutation status pilot scheme |
|
UKNEQAS for Leucocyte Immunophenotyping |
KIT D816V mutation statuspilot scheme |
|
UKNEQAS for Leucocyte Immunophenotyping |
BCR-ABL1 and AML translocations |
|
Sample swap |
MPL Exon 10 gene testing |
Antimicrobial Reference Laboratory
|
Scheme Provider |
Scheme |
|---|---|
|
UKNEQAS TDM |
Anti bacterial panel (vancomycin, teicoplanin, tobramycin, gentamicin, amikacin) |
|
UKNEQAS TDM |
Anti fungal panel (itraconazole, posaconazole, Flucytosine, voriconazole) |
|
Instand eV |
TDM 197 (Amikacin, Gentamicin, Tobramycin, Vancomycin) |
|
Instand eV |
TDM 193 (Teicoplanin) |
|
Instand eV |
TDM 198 (Chloramphenicol, Flucoazole, Posaconazole, Voriconazole, Flucytosine) |
|
Instand eV |
TDM 602 (itraconazole) |
|
SKML |
Anti-TB (Linezolid, Rifampicin, Ethambutol, Levofloxacin, Moxifloacin, Rifabutin) |
|
SKML |
Antiviral drugs (Aciclovir, Ganciclovir) |
Bacteriology
|
Scheme Provider |
Scheme |
|
Lab Quality |
CSF |
|
Lab Quality |
Gram Staining |
|
Lab Quality |
H.pylori Faecal Antigen detection |
|
Lab Quality |
Urine cell count |
|
Lab Quality |
Blood cultures |
|
Lab Quality |
Urine culture |
|
Lab Quality |
Multi-drug resistant GNBs |
|
LGC |
Gram stain – Bacterial vaginitis |
|
LGC |
Crypto/Giardia Faecal Antigen detection |
|
QCMD |
MALDI-Tof Identification of bacterial isolates |
|
UKNEQAS - Microbiology |
AAFB microscopy |
|
UKNEQAS - Microbiology |
Antimicrobial Sensitivities |
|
UKNEQAS - Microbiology |
C.difficile toxin |
|
UKNEQAS - Microbiology |
Faecal Parasites |
|
UKNEQAS - Microbiology |
Genital Pathogens |
|
UKNEQAS - Microbiology |
General Bacteriology |
|
UKNEQAS - Microbiology |
MRSA Screening |
|
UKNEQAS - Microbiology |
Mycobacterium Culture |
|
UKNEQAS - Microbiology |
Mycology ID (Routine dermatology) |
|
UKNEQAS - Microbiology |
Mycology sensitivities |
|
UKNEQAS - Microbiology |
Mycobacterium molecular procedures |
|
UKNEQAS - Microbiology |
Urinary antigen detection (Legionella sp, Strep. pneumo) |
|
Inter-laboratory exchange |
Crypto/Giardia screening |
Mycology Reference Laboratory
|
Scheme Provider |
Scheme |
|---|---|
|
UKNEQAS - Immunology |
Aspergillus Fumigatus |
|
UKNEQAS - Immunology |
Avian Precipitins - Pigeon |
|
UKNEQAS - Immunology |
Avian Precipitins - Budgerigar |
|
UKNEQAS - Immunology |
M.faeni |
|
UKNEQAS - Immunology |
Candida albicans |
|
UKNEQAS - Immunology |
Fungal and related antigens |
|
UKNEQAS |
Fungal Biomarkers |
|
Instand eV |
Dematophytes, Yeasts, Mould fungus (491) |
|
Instand eV |
Yeasts (490) |
|
Instand eV |
Cryptococcal antigen (481) |
|
Instand eV |
Candida Antigen & Antibody (480) |
|
QCMD |
Candida PCR |
|
QCMD |
Aspergillus PCR |
|
Inter-laboratory exchange |
Beta Glucan |
|
Inter-laboratory exchange |
Aspergillus antigen |
|
Lab Quality |
Fungal Culture |
Virology
|
Scheme Provider |
Scheme |
|
CSCQ |
Lyme borreliosis |
|
Instand eV |
Chlamydia serology distribution |
|
Instand eV |
Q fever serology distribution |
|
Instand eV |
SARS-CoV-2 Molecular detection |
|
Instand eV |
Streptococcal antibodies detection |
|
Instand eV |
SARS-CoV-2 genome detection |
|
Instand eV |
Influenza typing including avian |
|
Lab Quality |
B burgdorferi antibodies |
|
Lab Quality |
H pylori antibodies distribution |
|
Lab Quality |
Herpes Simplex Antibodies |
|
Lab Quality |
M. pneumoniae serology distribution |
|
Lab Quality |
Measles Abs distribution |
|
Lab Quality |
Mumps IgG & IgM antibody |
|
Lab Quality |
Parvovirus B19 Abs distribution |
|
Lab Quality |
Rubella Abs distribution |
|
Lab Quality |
Hepatitis E antibodies |
|
Lab Quality |
H pylori antibodies distribution |
|
Lab Quality |
Pertussis Serology |
|
Lab Quality |
CMV Serology (Inc Avidity) |
|
Lab Quality |
SARS-CoV-NA detection |
|
Lab Quality |
SARS-CoV Serology |
|
Lab Quality |
STD (TV & MG) NAAT detection |
|
QCMD |
Adenovirus DNA detection |
|
QCMD |
B. pertussis DNA detection |
|
QCMD |
BK DNA detection |
|
QCMD |
C. trachomatis DNA detection |
|
QCMD |
CMV DNA (whole blood) detection |
|
QCMD |
CMV DNA detection |
|
QCMD |
EBV DNA (whole blood) detection |
|
QCMD |
EBV DNA detection |
|
QCMD |
Enterovirus RNA detection |
|
QCMD |
HBV DNA quantification |
|
QCMD |
HCV Genotype identification |
|
QCMD |
HCV RNA quantification |
|
QCMD |
HHV6 DNA detection |
|
QCMD |
HIV RNA quantification |
|
QCMD |
HSV DNA detection |
|
QCMD |
Influenza A & B RNA detection |
|
QCMD |
Influenza Haemagglutinin Typing |
|
QCMD |
Measles RNA detection |
|
QCMD |
Metapneumonvirus RNA detection |
|
QCMD |
N. gonorrhoeae detection |
|
QCMD |
Norovirus RNA detection |
|
QCMD |
Parainfluenza RNA detection |
|
QCMD |
Parvovirus B19 DNA detection |
|
QCMD |
Rhinovirus RNA detection |
|
QCMD |
RSV RNA detection |
|
QCMD |
VZV DNA detection |
|
QCMD |
Viral Gastroenteritis |
|
QCMD |
SARS-COV-2 RNA detection |
|
RCPAQAP |
Chlamydia Genus serology |
|
RCPAQAP |
Q fever serology |
|
UKNEQAS - Microbiology |
Anti-HBs serology |
|
UKNEQAS - Microbiology |
Blood borne viruses serology |
|
UKNEQAS - Microbiology |
Blood donor screen serology |
|
UKNEQAS - Microbiology |
C. trachomatis & N. gonorrhoeae NAAT detection |
|
UKNEQAS - Microbiology |
CMV DNA quantification |
|
UKNEQAS - Microbiology |
Diagnostic serology hepatitis |
|
UKNEQAS - Microbiology |
EBV DNA Quantification |
|
UKNEQAS - Microbiology |
HBV DNA quantification |
|
UKNEQAS - Microbiology |
Hepatitis B serology |
|
UKNEQAS - Microbiology |
Hepatitis C RNA detection |
|
UKNEQAS - Microbiology |
Hepatitis C serology |
|
UKNEQAS - Microbiology |
Hepatitis E serology |
|
UKNEQAS - Microbiology |
HIV RNA quantification |
|
UKNEQAS - Microbiology |
HIV serology |
|
UKNEQAS - Microbiology |
Immunity screen |
|
UKNEQAS - Microbiology |
Measles IgG & Mumps IgG serology |
|
UKNEQAS - Microbiology |
Molecular detection of respiratory viruses |
|
UKNEQAS - Microbiology |
Multiplex detection of respiratory viruses |
|
UKNEQAS - Microbiology |
Parvo B19 and Rubella serology |
|
UKNEQAS - Microbiology |
Rubella IgG serology |
|
UKNEQAS - Microbiology |
Syphilis serology |
|
UKNEQAS - Microbiology |
Toxoplasma serology |
|
UKNEQAS - Microbiology |
Viral gastroenteritis - Molecular detection |
|
UKNEQAS - Microbiology |
Viruses in CSF (molecular) distribution |
|
UKNEQAS - Microbiology |
SARS-COV-2 (molecular detection) |
|
WEQAS |
SARS-COV-2 Antibodies |
Clinical Biochemistry
|
Scheme Provider |
Scheme |
|
WEQAS POCT |
Bilirubin |
|
WEQAS - General Chemistry |
ACE, Adjusted Calcium |
|
WEQAS |
pH meter |
|
UKNEQAS |
Cholinesterase activity and phenotyping |
| UKNEQAS Peptide Hormones 1 | AMH |
|
UK NEQAS- POCT |
Automated Differential Leucocyte Count |
|
UK NEQAS Immunosuppressant (IPT) |
Tacrolimus (FK506) Cyclosporin (CyA), Sirolimus (SIR) |
|
UK NEQAS for MSS - 1st Trimester |
free bHCG |
|
UK NEQAS - Trace Metals |
Aluminium |
|
UK NEQAS - Newborn Screening |
Glutaryl carnitine (C5DC) |
|
UK NEQAS - general Chemistry assays |
AFP (Tumour) , Albumin |
|
RIQAS |
Procalcitonin |
|
RfB (German scheme for neonatal screening) |
17-OH Progesterone |
|
LGC - (clinical assays)TAS |
Carbemazepine |
|
LGC - (coronial assays) |
Amphetamine |
|
ERNDIM Special Urine |
Galactitol |
|
ERNDIM Special Assays in Serum |
7-Dehydrocholersterol |
|
ERNDIM Quantitative Organics |
Methylmalonic Acid |
|
ERNDIM Quantitative Amino Acids in Serum |
Quantitative Amino Acids (plasma) |
|
ERNDIM Qualitative Organic Acids |
Urine Organic Acids |
|
ERNDIM Acylcarnitines in Serum |
Acylcarnitine |
|
ERNDIM Acylcarnitines in Dried Blood Spots (Qualitative) |
Acylcarnitines (bloodspots) |
|
ERNDIM - Special Assays in Dried Bloodspots |
Diet Phenylalanine |
|
EQALIS |
Iohexol |
|
Diagnostic Proficiency Testing (DPT) |
Urine Organic Acids |
|
DEQAS |
Report for performance of FTCS |
|
CDC |
Galactosaemia Screen |
Immunology
|
Scheme Provider |
Scheme |
|
UK NEQAS |
Paraneoplastic Antibodies |
|
UK NEQAS |
B2Microglobulin |
|
UK NEQAS |
C1 Inhibitor and Functional Complement |
|
UK NEQAS |
Monoclonal Protein Identification |
|
UK NEQAS |
General Autoimmune Serology |
|
UK NEQAS |
Nuclear and Related Antibodies (Hep2) |
|
UK NEQAS |
Nuclear and Related Antibodies (rodent tissue ANA and critidia) |
|
UK NEQAS |
Bullous Dermatosis |
|
UK NEQAS |
IgG Subclasses |
|
UK NEQAS |
Total IgE |
|
UK NEQAS |
Allergen Specific IgE |
|
UK NEQAS |
ANCA/GBM Antibodies |
|
UK NEQAS |
Coeliac Disease Antibodies |
|
UK NEQAS |
Diabetic Markers |
|
UK NEQAS |
Specific Proteins Dist |
|
UK NEQAS |
CSF for Oligonclonal Bands |
|
UK NEQAS |
Faecal Markers of Bowel Inflammation |
|
UK NEQAS |
CSF for Beta 2 Transferrin |
|
UK NEQAS |
Alpha 1 Antitrypsin Phenotyping |
|
UK NEQAS |
ACHR Antibodies |
|
UK NEQAS |
Phospholipid Antibodies |
|
UK NEQAS |
Mast Cell Tryptase |
|
UK NEQAS |
Fungal Related Antigens |
|
UK NEQAS |
Immune Monitoring CD4 Counts |
|
UK NEQAS |
Leukaemia Immunophenotyping |
|
UK NEQAS |
Leukaemia Interpretation Scheme |
|
UK NEQAS |
MRD ALL |
|
UK NEQAS |
Interferon Gamma Release Assay - TB |
|
UK NEQAS |
PNH |
|
UK NEQAS |
Allergen Component Testing |
|
UK NEQAS |
ABO Titration |
|
UK NEQAS |
Scheme 1A HLA Phenotyping |
|
UK NEQAS |
Scheme 1B HLA-B27 Testing |
|
UK NEQAS |
Scheme 2A Cytotoxic Crossmatching - B cell with/without DTT |
|
UK NEQAS |
Scheme 2A Cytotoxic Crossmatching - T cell with/without DTT |
|
UK NEQAS |
Scheme 2B Crossmatching by Flow Cytometry - B cell |
|
UK NEQAS |
Scheme 2B Crossmatching by Flow Cytometry - T cell |
|
UK NEQAS |
Scheme 3 HLA Antibody Specificity Analysis |
|
UK NEQAS |
Scheme 4A1 HLA DNA Typing 1st Field Only |
|
UK NEQAS |
Scheme 4A2 HLA DNA Typing 2nd Field |
|
UK NEQAS |
Scheme 6 Antibody Detection |
|
UK NEQAS |
Scheme 7 HLA-B57:01 Typing |
|
UK NEQAS |
Scheme 8 'Disease' Typing HLA-DR/DQ/DP only |
|
UK NEQAS |
Cryoglobulin (pilot) |
|
UK NEQAS |
Myositis Associated Antibody |
|
UK NEQAS |
Faecal Pancreatic Elastase |
|
UK NEQAS |
MRD CLL (pilot) |
|
UK NEQAS |
MRD AML (pilot) |
|
UK NEQAS |
Educational Crossmatch Scheme |
|
WEQAS |
FOB/FIT (pilot) |
|
UK NEQAS |
Phospholipase A2 Receptor Antibody |
|
UK NEQAS |
CSF Immunophenotyping (pilot) |
| UK NEQAS | Alkaline Phsphatase (ALP) Isoenzymes (pilot) |
Cellular Pathology
|
Scheme Provider |
Scheme |
|
UK NEQAS |
UK NEQAS for Cellular Pathology Tecnique - General |
|
UK NEQAS |
UK NEQAS for Cellular Pathology Tecnique - Cytology |
|
UK NEQAS |
NEQAS for Immunohistochemistry - General |
|
UK NEQAS |
NEQAS for Immunohistochemistry - Lymphoma |
|
UK NEQAS |
NEQAS for Immunohistochemistry - Breast |
|
UK NEQAS |
NEQAS for Immunohistochemistry - HER2 |
|
SW Regional EQA |
SW Regional EQA Papanicolaou in Cervical Cytology |
|
SW Regional EQA |
SW Region Cervical Cytology scheme |
|
National scheme |
HPV |
|
National Gynaecological Histology Scheme |
Interpretive Schemes pathologists practicing in specialty |
|
Regional Histopathology EQA Scheme |
Interpretive Schemes pathologists practicing in specialty |
|
GI Pathology EQA Scheme |
Interpretive Schemes pathologists practicing in specialty |
|
Bowel Cancer Screening |
Interpretive Schemes pathologists practicing in specialty |
|
National Uropathology EQA Scheme |
Interpretive Schemes pathologists practicing in specialty |
|
National Dermatology EQA Scheme |
Interpretive Schemes pathologists practicing in specialty |
|
National Prostate Core EQA Scheme |
Interpretive Schemes pathologists practicing in specialty |
|
National Renal Pathology EQA Scheme |
Interpretive Schemes pathologists practicing in specialty |
|
National Renal Transplant EQA Scheme |
Interpretive Schemes pathologists practicing in specialty |
|
Regional Cervical Cytopathology EQA Scheme |
Interpretive Schemes pathologists practicing in specialty |
Haematology
|
Scheme Provider |
Scheme |
|
UK NEQAS |
Full Blood Count |
|
UK NEQAS |
G6PD |
|
UK NEQAS |
Auto WBC Differential |
|
UK NEQAS |
Retic Count |
|
UK NEQAS |
Haemoglobinopathy |
|
UK NEQAS |
Sickle Screen |
|
UK NEQAS |
Cytochemistry, FE Stain |
|
UK NEQAS |
Blood Film Morphology/Parasitology |
|
UK NEQAS |
Manual WBC Differential |
|
UK NEQAS |
Rapid Malaria Antigen Test |
|
UK NEQAS |
nRBCc |
|
UK NEQAS |
Plasma Viscosity |
|
UK NEQAS |
Ferritin |
|
UK NEQAS |
Intrinsic Factor Antibodies |
|
UK NEQAS |
B12/Folate |
|
UK NEQAS |
Erythropoietin |
|
UK NEQAS |
INR/PT |
|
UK NEQAS |
APTT |
|
UK NEQAS |
Thrombin Time |
|
UK NEQAS |
Heparin Dosage Assessment |
|
UK NEQAS |
Heparin Assay |
|
UK NEQAS |
Fibrinogen |
|
UK NEQAS |
D-Dimer |
|
UK NEQAS |
Coagulation Factor Assays: VIII, IX II,V,VII,XI,XII,FXIII |
|
UK NEQAS |
VWF RiCof VWF antigen |
|
UK NEQAS |
Antithrombin Activity |
|
UK NEQAS |
Protein C Activity |
|
UK NEQAS |
Free Protein S Antigen |
|
UK NEQAS |
Activated Protein C resistance |
|
UK NEQAS |
Lupus Antigoagulant |
|
UK NEQAS |
Blood Transfusion |
|
UK NEQAS |
BTLP (Blood Transfusion) |
|
UK NEQAS |
FMH (Blood Transfusion) Acid Elution |
|
ECAT (Dutch EQA Scheme) |
Anti-Xa tests |